Cargando…
Indolent peritoneal mesothelioma: PI3K-mTOR inhibitors as a novel therapeutic strategy
Peritoneal mesothelioma (MPeM) is a scarce abdominal-pelvic malignancy that presents with non-specific features and exhibits a wide clinical spectrum from indolent to aggressive disease. Due to it being a rare entity, there is a lack of understanding of its molecular drivers. Most treatment data are...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
ESMO Open
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519796/ https://www.ncbi.nlm.nih.gov/pubmed/28761723 http://dx.doi.org/10.1136/esmoopen-2016-000101 |